← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Pharmatech, Inc.
Denver, CO
$1,769,329
Total funding
2
Grants
Funding over time
peak $925.3K · FY2010–13$1M$750K$500K$250K$0
'10
'11
'12
'13
Funding mix
By agency
NIH$1,769,329 · 2
By mechanism
R44$1,614,622 · 1
R43$154,707 · 1
Investigators at Pharmatech, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
A Patient Centered Approach to Enrolling Rare Cancer Patients in Clinical Trials$925,328
R44 · FY2013 · CA
A Patient Centered Approach to Enrolling Rare Cancer Patients in Clinical Trials$689,294
R44 · FY2012 · CA
A Patient-Centered Approach to Enrolling Rare Cancer Patients in Clinical Trials$154,707
R43 · FY2010 · CA